This inventor holds 10 USPTO granted patents and 11 published patent applications and 2 EPO patents. Top assignees: The General Hospital Corporation, Canthera Therapeutics Inc., Harvard College. Active years: 2012-2023.
Company Filing History:
10 out of 3,070 
2 out of 2 
1 out of 3,071 
Years Active: 2012-2023
Title: Inventor Spotlight: Anna I Mandinova
Introduction
Anna I Mandinova is an accomplished inventor based in Newton, MA, USA. With a remarkable portfolio of 10 patents, she has made significant contributions to the field of biomedical technologies, specifically in the areas related to innovative delivery methods and treatments. Her research focuses on developing novel applications that aim to enhance medical treatment and patient outcomes.
Latest Patents
Among her latest inventions is a patent for a "Systemic delivery of polypeptides." This groundbreaking method enables the systemic delivery of therapeutic polypeptides by creating genetically modified skin cells. Through the topical introduction of a genetically engineered virus that delivers a nucleic acid encoding the polypeptide, skin cells can express and secrete therapeutic agents directly into the subject's circulatory system.
Another noteworthy patent is for "Agents and methods for treating and preventing seborrheic keratosis." This patent outlines methods for isolating and culturing seborrheic keratosis cells ex vivo. It also provides comprehensive screening assays using these cultured cells and innovative methods for treating seborrheic keratosis in patients, showcasing her dedication to advancing healthcare solutions.
Career Highlights
Anna has held pivotal positions in respected organizations such as The General Hospital Corporation and Canthera Therapeutics Inc. Her work with these institutions has allowed her to translate her innovative ideas into impactful medical applications, ultimately benefiting numerous patients.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Sam W. Lee and Victor A. Neel. These partnerships have fostered a dynamic exchange of ideas and knowledge, leading to groundbreaking advancements in her field.
Conclusion
Anna I Mandinova exemplifies the spirit of innovation and dedication as an inventor. Her contributions to the medical field, evidenced by her multiple patents and collaborative efforts, highlight the importance of continuing to push the boundaries of science and technology. Anna's work not only reflects her brilliance as an inventor but also her commitment to improving healthcare for future generations.